A fragment integrational approach to GPCR inhibition: Identification of a high affinity small molecule CXCR4 antagonist.

MLA

Fang, Xiong, et al. “A Fragment Integrational Approach to GPCR Inhibition: Identification of a High Affinity Small Molecule CXCR4 Antagonist.” European Journal of Medicinal Chemistry, vol. 231, Mar. 2022, p. 114150. EBSCOhost, https://doi.org/10.1016/j.ejmech.2022.114150.

APA

Fang, X., Meng, Q., Zhang, H., Fang, X., Huang, L. S., Zhang, X., Schooley, R. T., Ciechanover, A., An, J., Xu, Y., & Huang, Z. (2022). A fragment integrational approach to GPCR inhibition: Identification of a high affinity small molecule CXCR4 antagonist. European Journal of Medicinal Chemistry, 231, 114150. https://doi.org/10.1016/j.ejmech.2022.114150

Chicago

Fang, Xiong, Qian Meng, Huijun Zhang, Xiao Fang, Lina S Huang, Xingquan Zhang, Robert T Schooley, et al. 2022. “A Fragment Integrational Approach to GPCR Inhibition: Identification of a High Affinity Small Molecule CXCR4 Antagonist.” European Journal of Medicinal Chemistry 231 (March): 114150. doi:10.1016/j.ejmech.2022.114150.